MICROTUBULES IN TESTICULAR TOXICITY OF CARBENDAZIM
多菌灵睾丸毒性中的微管
基本信息
- 批准号:2018589
- 负责人:
- 金额:$ 23.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Investigator's Abstract): Benomyl and its
metabolite carbendazim are benzimidazole fungicides which cause testicular
toxicity in rats at dose levels where no other organ system is affected. A
recent study has supplied strong evidence that carbenazim (CBZ), and not
benomyl, is responsible for testicular damage. Histopathologically,
testicular toxicity after CBZ administration is characterized by a stage
specific sloughing of the seminiferous epithelium. CBZ is known to inhibit
microtubule assembly but the relationship of this to the cellular events
which underlie sloughing is not known. The hypothesis central to the
present proposal is that the singular sensitivity of the testis to CBZ
toxicity is the result of disruption of a specific microtubule associated
protein (MAP)/tubulin interaction only found in the testis with resultant
loss of microtubule assembly and decreased phosphorylation of MAP or tubulin
protein(s). A model is presented which addresses the role of testis
microtubule vs. intermediate filament structures in the stage specific
sloughing induced by CBZ. The first specific aim is to establish that the
effect of CBZ on microtubule assembly is specific for testis microtubule
assembly and involves disruption of a testis specific MAP-tubulin
interaction. The second specific aim is to identify the MAP/tubulin
testis-specific proteins which are affected by CBZ and address the
possibility that CBZ induced changes in protein phosphorylation play a role
in cytoskeletal collapse. The final specific aim will determine the
relationship to sloughing of early cytoskeletal changes induced by CBZ
administered at dose levels both above and below the sloughing threshold in
normal rats and vim-knockout mice. Preliminary immunocytochemical data has
indicated that, concomitant with loss of microtubule structure, intermediate
filaments collapse towards the basal membrane. A model is proposed which
explains the stage specific effects of CBZ in terms of the function of
microtubules and intermediate filaments at different stages of germ cell
development. The vimentin-knockout mouse provides an excellent experimental
model for testing the role of intermediate filaments in the sloughing events
which follow CBZ administration.
描述(改编自研究者摘要):苯菌灵及其
代谢物多菌灵是苯并咪唑杀真菌剂,
在不影响其他器官系统的剂量水平下对大鼠的毒性。 一
最近的研究提供了强有力的证据表明,多菌灵(CBZ),而不是
苯菌灵是造成睾丸损伤的罪魁祸首 组织病理学上,
CBZ给药后的睾丸毒性的特征在于
生精上皮的特殊脱落。 已知CBZ抑制
微管组装,但这与细胞事件的关系
其作为脱落的基础是未知的。 这一假设的核心是
目前的建议是,睾丸对CBZ的单一敏感性
毒性是特定微管相关的破坏的结果,
蛋白质(MAP)/微管蛋白相互作用仅见于睾丸,
微管组装的丧失和MAP或微管蛋白磷酸化的降低
蛋白质。 提出了一个解决睾丸作用的模型
阶段特异性微管与中间丝结构
CBZ引起的坍塌。 第一个具体目标是,
CBZ对微管组装影响是睾丸微管特异性的
组装并涉及睾丸特异性微管蛋白的破坏
互动 第二个具体目标是鉴定MAP/微管蛋白
睾丸特异性蛋白,受CBZ影响,并解决
CBZ诱导的蛋白质磷酸化变化可能在
在细胞骨架崩溃。 最终的具体目标将决定
CBZ诱导的早期细胞骨架变化与脱落的关系
以高于和低于脱落阈值的剂量水平给药,
正常大鼠和病毒敲除小鼠。 初步的免疫细胞化学数据
表明,伴随着微管结构的丧失,
纤维向基底膜收缩。 提出了一种模型,
解释了CBZ在功能方面的阶段特异性效应,
生殖细胞不同时期的微管和中间丝
发展 波形蛋白敲除小鼠提供了一个极好的实验
用于测试中间丝在坍塌事件中的作用的模型
CBZ给药后。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARION G MILLER其他文献
MARION G MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARION G MILLER', 18)}}的其他基金
Short Term Educational Experiences for Research (STEER) in Environmental Health S
环境健康研究短期教育经验(STEER)
- 批准号:
7743108 - 财政年份:2008
- 资助金额:
$ 23.21万 - 项目类别:
Short Term Educational Experiences for Research (STEER) in Environmental Health S
环境健康研究短期教育经验(STEER)
- 批准号:
7340671 - 财政年份:2008
- 资助金额:
$ 23.21万 - 项目类别:
MICROTUBULES IN TESTICULAR TOXICITY OF CARBENDAZIM
多菌灵睾丸毒性中的微管
- 批准号:
6055938 - 财政年份:1997
- 资助金额:
$ 23.21万 - 项目类别:
MICROTUBULES IN TESTICULAR TOXICITY OF CARBENDAZIM
多菌灵睾丸毒性中的微管
- 批准号:
2770767 - 财政年份:1997
- 资助金额:
$ 23.21万 - 项目类别:
MECHANISMS OF 1,3-DINITROBENZENE TESTICULAR TOXICITY
1,3-二硝基苯睾丸毒性机制
- 批准号:
2154507 - 财政年份:1993
- 资助金额:
$ 23.21万 - 项目类别:
MECHANISMS OF 1,3-DINITROBENZENE TESTICULAR TOXICITY
1,3-二硝基苯睾丸毒性机制
- 批准号:
2154508 - 财政年份:1993
- 资助金额:
$ 23.21万 - 项目类别:
MECHANISMS OF 1,3-DINITROBENZENE TESTICULAR TOXICITY
1,3-二硝基苯睾丸毒性机制
- 批准号:
3253986 - 财政年份:1993
- 资助金额:
$ 23.21万 - 项目类别:
相似海外基金
Budding Uninhibited by Benzimidazoles 1の腎臓病進展に与える分子機構の解明
阐明苯咪唑出芽不受抑制1对肾脏疾病进展的分子机制
- 批准号:
23K07700 - 财政年份:2023
- 资助金额:
$ 23.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
新型苯并咪唑类药物治疗阿尔茨海默病的优化与评价
- 批准号:
10408007 - 财政年份:2021
- 资助金额:
$ 23.21万 - 项目类别:
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
新型苯并咪唑类药物治疗阿尔茨海默病的优化与评价
- 批准号:
10654786 - 财政年份:2021
- 资助金额:
$ 23.21万 - 项目类别:
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
新型苯并咪唑类药物治疗阿尔茨海默病的优化与评价
- 批准号:
10745558 - 财政年份:2021
- 资助金额:
$ 23.21万 - 项目类别:
Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease
新型苯并咪唑类药物治疗阿尔茨海默病的优化与评价
- 批准号:
10185192 - 财政年份:2021
- 资助金额:
$ 23.21万 - 项目类别:
Rational Design, Synthesis and Biological Evaluation of Benzimidazoles; Towards a Novel Therapy Selectively Targeting C. neoformans beta-tubulin
苯并咪唑类药物的合理设计、合成及生物学评价;
- 批准号:
MR/N023005/1 - 财政年份:2016
- 资助金额:
$ 23.21万 - 项目类别:
Research Grant
Directed ortho metalation approach to C-7-substituted benzimidazoles and indazoles
C-7 取代苯并咪唑和吲唑的定向邻位金属化方法
- 批准号:
424608-2011 - 财政年份:2013
- 资助金额:
$ 23.21万 - 项目类别:
Industrial R&D Fellowships (IRDF)
Directed ortho metalation approach to C-7-substituted benzimidazoles and indazoles
C-7 取代苯并咪唑和吲唑的定向邻位金属化方法
- 批准号:
424608-2011 - 财政年份:2012
- 资助金额:
$ 23.21万 - 项目类别:
Industrial R&D Fellowships (IRDF)
C-7 Functionalisation of Benzimidazoles via Directed C-H Functionalisation
通过定向 C-H 官能化对苯并咪唑进行 C-7 官能化
- 批准号:
425727-2012 - 财政年份:2012
- 资助金额:
$ 23.21万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
BIS-BENZIMIDAZOLES AS ANTI-OPPORTUNISTIC INFECTION AGENTS
双苯并咪唑作为抗机会性感染剂
- 批准号:
3747392 - 财政年份:
- 资助金额:
$ 23.21万 - 项目类别:














{{item.name}}会员




